AUM Biosciences Enters into Collaboration with Roche for Clinical Development of AUM001 in Combination with anti-PD-L1 Therapy in Solid Tumor Indications

Your email address will not be published. Required fields are marked *

Comment

Save my name, email, and website in this browser for the next time I comment.